Migraine is a disabling neurological disorder, diagnosis of which is based on clinical criteria.
A shortcoming of these criteria is that they do not fully capture the heterogeneity of migraine…

Migraine affects over a billion individuals worldwide but its genetic underpinning remains
largely unknown. Here, we performed a genome-wide association study of 102,084 migraine …

Integration of genetic, phenotypic and epigenetic data will help to identify the biological
mechanisms by which genetic factors contribute to migraine pathogenesis. Recent studies show …

Calcitonin gene-related peptide (CGRP) is a neuropeptide with a pivotal role in the pathophysiology
of migraine. Blockade of CGRP is a new therapeutic target for patients with migraine…

Aim To determine whether our E-diary can be used to diagnose migraine and provide more
reliable migraine-related frequency numbers compared to patients’ self-reported estimates. …

Objective The objective of this study was to aggregate data for the first genomewide
association study meta‐analysis of cluster headache, to identify genetic risk variants, and gain …

Progress in high-throughput metabolic profiling provides unprecedented opportunities to
obtain insights into the effects of drugs on human metabolism. The Biobanking BioMolecular …

Objective Identifying common genetic variants that confer genetic risk for cluster headache.
Methods We conducted a case–control study in the Dutch Leiden University Cluster …

Cluster headache and migraine are regarded as distinct primary headaches. While cluster
headache and migraine differ in multiple aspects such as gender-related and headache …

Background This narrative review aims to discuss several common neurological and psychiatric
disorders that show comorbidity with migraine. Not only can we gain pathophysiological …